Dilon Technologies: Study Determines Breast-Specific Gamma Imaging Is More Effective Than Ultrasound in Patients With Complex Breast Tissue
10/6/2010 7:19:24 AM
More...
|
Dilon Technologies: First Lesion-Localization System for Molecular Breast Imaging Proves to Be Highly Effective for Gamma-Guided Biopsy: Results Presented Today at RSNA
12/3/2009 1:11:47 PM
More...
|
Dilon Technologies: Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI)
11/19/2009 10:45:39 AM
More...
|
Dilon Technologies: Breast Cancer Detection Goes Beyond Mammography to See What Matters New Technology
10/13/2009 8:48:10 AM
More...
|
Dilon Technologies Joins Forces With Philips Healthcare for Women's Health Solutions
10/12/2009 7:03:18 AM
More...
|
Dilon Technologies: Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis
10/9/2009 9:05:51 AM
More...
|
Dilon Technologies Release: Breast-Specific Gamma Imaging (BSGI) Can Reduce the Number of Unnecessary Breast Biopsies When Compared to MRI
3/18/2009 11:23:31 AM
More...
|
Dilon Technologies's Breast-Specific Gamma Imaging (BSGI) Offers Greater Sensitivity Over Mammography, Ultrasound and MRI
3/3/2009 8:43:47 AM
More...
|
Dilon Technologies Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients
2/27/2009 10:15:14 AM
More...
|
Dilon Technologies Leads Molecular Breast Imaging Expansion; 35 Percent Increase in Sales
2/10/2009 6:47:31 AM
More...
|
|